Rotraxate
Rotraxate (TEI 5103) is an orally active anti-ulcer compound. Rotraxate can increase blood flow to the gastric mucosa and promote the integrity of the gastric mucosa. Rotraxate can be used to study the protective effects of drugs on the gastric mucosa, especially in investigating how drugs can prevent or treat gastric ulcers by acting directly on the gastric mucosa[1].
Product Specifications
CAS Number
92071-51-7
Product Name Alternative
TEI 5103; TG 51
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/rotraxate.html
Smiles
O=C([C@H]1CC[C@@H](CC1)CN)C2=CC=C(C=C2)CCC(O)=O
Molecular Formula
C17H23NO3
Molecular Weight
289.37
References & Citations
[1]Tanabe H, et al. A novel anti-ulcer agent (TEI-5103) acting directly on the gastric mucosa from lumen. II: Distribution of TEI-5103 to gastric mucosa in rats[J]. Drug Metabolism and Pharmacokinetics, 1988, 3 (1) : 33-40.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VD2N283 1 Each
Mouse Anti-Rat Inhibin Alpha (INHa) Monoclonal Antibody
Sign In for Pricing
View Details 
031722-APC 200 µL
AIF1, NT (AIF1, G1, IBA1, Allograft inflammatory factor 1, Ionized calcium-binding adapter molecule 1, Protein G1) (APC)
Sign In for Pricing
View Details 252151-ML405 100 µL
STAP2 (Signal Transducing Adaptor Family Member 2, BKS, FLJ20234) (MaxLight 405) discontinued
Sign In for Pricing
View Details